Bio-Rad anti-ranibizumab antibodies

Thursday, 02 August, 2018 | Supplied by: Bio-Rad Laboratories Pty Ltd



Bio-Rad Laboratories has launched a range of recombinant monoclonal anti-ranibizumab antibodies that are highly specific for the monoclonal antibody drug ranibizumab (Lucentis) or the complex of ranibizumab with its target, vascular endothelial growth factor A (VEGF-A).

Ranibizumab is used for the treatment of wet age-related macular degeneration (AMD), a common form of age-related vision loss, and for macular edema and diabetic retinopathy. The anti-ranibizumab antibodies are inhibitory, non-inhibitory and drug-target complex specific antibodies and designed for use in pharmacokinetic (PK) and immunogenicity assays for ranibizumab and biosimilars.

Ranibizumab is a Fab fragment drug and is present at low levels in patient samples, which presents challenges for PK assay design and sensitivity. Bio-Rad’s high-affinity ranibizumab-VEGF complex specific antibody overcomes those challenges by enabling the development of a PK antigen capture assay to measure free drug.

The anti-idiotypic antibodies are generated using Human Combinatorial Antibody Library (HuCAL) and CysDisplay, a proprietary method of phage display with guided selection methods to obtain highly targeted reagents. The recombinant production method also ensures a consistent and secure supply.

The anti-ranibizumab antibodies are approved for in vitro research and for commercial applications of in vitro testing services that support preclinical and clinical drug and biosimilar development and patient monitoring.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Matreya phosphosphingolipids for lipidomics research

Matreya offers an extensive list of phosphosphingolipids including sphingomyelins,...

CellSera foetal bovine serum

CellSera's foetal bovine serum is sterile filtered using Sartorius Stedim Biotech triple 0.1...

Novozymes Remify Everis 100 L enzyme solution for surgical device cleaning

The product is a phosphodiesterase (PDE) — a nuclease — that speeds up reactions and...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd